Observational Registry for Cancer Patients

This is an observational study, called a registry, for people with cancer who are receiving care at participating oncology centers. The study is collecting information about your health, the treatments you receive, and how you respond to those treatments. You will also be asked to complete surveys. The goal is to gather detailed and organized information to help researchers better understand cancer and to make it easier for more patients to take part in future clinical trials. We are looking to enroll up to 20,000 adults, aged 18 to 120 years old. The main goal is to track how long patients continue their treatment. The current status of this study is unclear.

Study design
This is an observational registry designed to collect data from up to 20,000 participants.
What's involved
You would provide signed informed consent and participate in data collection, which includes baseline information, treatment details, outcome data, and patient surveys.
Compensation
Not stated in the trial record.
Follow-up
Data will be collected, analyzed, and presented regularly over time, indicating ongoing follow-up.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06877884

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

Recruiting
Not specifiedAges 18+Observational
N-Power Medicine
~20,000 participants
Updated 2025-10-20 on ClinicalTrials.gov

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Treatment Effectiveness - Time to treatment discontinuation
Measured over This is an open-ended registry where data will be collected, analysed and presented regularly over time.
Cancer
7 sites across 6 states
Delaware2
California1
Illinois1
New Mexico1
Pennsylvania1
Texas1

Opens a ready-to-send draft in your own email app — review before sending.

  • Treatment Effectiveness - Time to treatment discontinuationThis is an open-ended registry where data will be collected, analysed and presented regularly over time.

    Effectiveness outcomes of treatments used in routine clinical care (such as for instance time to treatment discontinuation ) will be captured